264 related articles for article (PubMed ID: 9049233)
1. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
Herion D; Hoofnagle JH
Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
[No Abstract] [Full Text] [Related]
2. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
Kobayashi M; Watanabe K; Ishigami M; Murase K; Ito H; Ukai K; Yano M; Takagi K; Hattori M; Kakumu S; Yoshioka K
Am J Gastroenterol; 2002 Apr; 97(4):988-98. PubMed ID: 12003437
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatitis C virus genotype 4.
Abdo AA; Lee SS
J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
[TBL] [Abstract][Full Text] [Related]
4. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
Shedlofsky SI
Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
Brechot C
Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
[No Abstract] [Full Text] [Related]
6. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
[TBL] [Abstract][Full Text] [Related]
7. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
[No Abstract] [Full Text] [Related]
8. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus: prospects for future therapies.
Wilkinson T
Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
[TBL] [Abstract][Full Text] [Related]
11. HCV genotype 5: epidemiology and spread of an uncommon genotype.
Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
[No Abstract] [Full Text] [Related]
12. [Recent progress in the treatment of interferon-resistant hepatitis C].
Kumada M
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1759-62. PubMed ID: 10581760
[No Abstract] [Full Text] [Related]
13. [Hepatitis C virus genotype 4: epidemiology and treatment].
Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
[No Abstract] [Full Text] [Related]
14. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
Feld JJ; Hoofnagle JH
Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hepatitis C. Different modalities based on viral genotype].
Pariente A
Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
[No Abstract] [Full Text] [Related]
16. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.
Donadel E; Pontisso P; Ruvoletto MG; Gerotto M; De Salvo G; Chemello L; Casarin C; Alberti A
J Med Virol; 1998 Jan; 54(1):7-11. PubMed ID: 9443103
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of interferon resistance in hepatitis C.
Gretch D
Lancet; 2001 Nov; 358(9294):1662-4. PubMed ID: 11728538
[No Abstract] [Full Text] [Related]
18. [HCV genotype as a predictor of response to IFN therapy in chronic hepatitis C].
Ebata M; Fukuda Y; Koyama Y; Hayakawa T; Kumada T; Nakano S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):954-8. PubMed ID: 7563909
[No Abstract] [Full Text] [Related]
19. Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy.
Nishiguchi S; Ueda T; Itoh T; Enomoto M; Tanaka M; Tatsumi N; Fukuda K; Tamori A; Habu D; Takeda T; Otani S; Shiomi S
Hepatology; 2001 Jan; 33(1):241-7. PubMed ID: 11124842
[TBL] [Abstract][Full Text] [Related]
20. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]